Investor Relations
UMP is committed to fostering strong relationships and transparent communications with shareholders and investors.
We believe in being accountable, transparent, and fair to our shareholders and the investment community.
We keep our investors informed about our value development initiatives and business plans through proactive communication, empowering them to make informed decisions about their investments.
Latest Results
FY2023 Annual Results Highlights
HK$727.2m
Operating revenue
HK$170.5m
EBITDA
61.4%
Dividend payout ratio
Publications
Annual Results
For the year ended 30 June
Annual Results
For the year ended 30 June
2023 Annual Report
PDF
PDF
Press release
PDF
PDF
2023 Annual Results Presentation
PDF
PDF
2023 Annual Report
PDF
PDF
Press release
PDF
PDF
2023 Annual Results Presentation
PDF
PDF
Interim Results
For the six months ended 31 December
Interim Results
For the six months ended 31 December
2022-2023 Interim Report
PDF
PDF
2022-2023 Interim Report
PDF
PDF
Press Releases
Press Release
AXA and UMP announce strategic partnership
2023.11.21
Press Release
HKBU and UMP Healthcare sign MOU on integrative Chinese-Western medicine research collaboration
2023.10.11
Press Release
UMP Healthcare Announces FY2023 Annual Results
2023.09.21
Press Release
UMP Introduces Artificial Intelligence Technology for Enhanced Chest X-Ray Analysis Efficiency
2023.08.14
Press Release
UMP Healthcare Innov Centre signs MoU with Israel Export and International Cooperation Institute
2023.07.18
Press Release
UMP Healthcare Officially Opens Two ProCare Medical Imaging Centres
2023.07.10
Press Release
UMP Healthcare Announces FY2022/23 Interim Results Revenue Up 2% to HK$365.1 million
2023.02.23
Press Release
UMP Healthcare and Human Health Form Strategic Alliance
2023.02.16
Press Release
UMP Healthcare Innov Centre Stages Grand Opening Ceremony - The First Permanent Platform to Showcase the Latest Medical Technology in Hong Kong
2022.11.01
Press Release
UMP Inked Agreement with Humansa of the New World Group
2022.10.25
Press Release
UMP Cooperates with FTLife to Expand Cashless Treatment Coverage for Scheme Members
2022.10.05
Press Release
UMP Announces FY2022 Annual Results With Profit Attributable to Shareholders Up 107.2% to HK$72.2M
2022.09.26
Press Release
UMP Starts its Innov Centre and Partners with HKUST to Develop a Personalised
2022.09.08
Press Release
UMP is Opening New Medical Imaging Centre in Tsim Sha Tsui
2022.09.06
Press Release
UMP Healthcare Opens Another New PET-CT Imaging Centre in Spring 2023
2022.08.02
Press Release
UMP Will Open Its First Oncology Centre in Central Prime District
2022.06.20
Press Release
UMP Purchases Advanced Medical Imaging Equipment and Facilities
2022.05.12
Press Release
UMP Healthcare Expands Free Telemedicine and Drug Delivery to COVID-19 Patients Charity Foundation Receives HK$1 million Donation from CTFE Social Solutions
2022.04.01
Press Release
UMP Healthcare Offers Free Telemedicine Service to COVID-19 Patients
2022.02.23
Press Release
UMP Healthcare Joins Hands with ZA International in Launching ZA Health Pass
2021.07.22
Press Release
UMP Healthcare Chairman and CEO Dr. Sun Yiu Kwong Donates HK$5 Million to UMP Charity Foundation
2021.06.30
Press Release
UMP Healthcare Signs MOU with CUHK Jockey Club School of Public Health and Primary Care
2021.04.30
Press Release
UMP Healthcare Acquires MRI Services Provider in Hong Kong
2021.04.19
Press Release
UMP Healthcare Announces 2021 Interim Results
2021.02.25
Press Release
UMP Healthcare Enters into Strategic Partnership with Aurora Tele-Oncology
2020.12.08
Press Release
UMP Healthcare Empowers Primary Care with Training and Technology
2020.08.17
Press Release
UMP Healthcare Provides Online and Offline COVID-19 Assessment and Testing Services
2020.07.08
Press Release
UMP Healthcare Announces Cooperation with Taishan Charitable Association on Virtual Care Charity Program
2020.06.26
Press Release
China State Construction International Medical Industry Development Co., Limited and the UMP Healthcare Group reached a strategic cooperation
2020.04.14
Contact Investor Relations Team